Citizens Financial Group’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-10,000
Closed -$44.1K 697
2025
Q1
$44.1K Buy
+10,000
New +$46.9K ﹤0.01% 614
2023
Q1
Sell
-11,650
Closed -$11.7K 463
2022
Q4
$11.7K Sell
11,650
-25
-0.2% -$123 ﹤0.01% 417
2022
Q3
$12K Sell
11,675
-8,250
-41% -$52K ﹤0.01% 408
2022
Q2
$20K Sell
19,925
-28,400
-59% -$316K ﹤0.01% 420
2022
Q1
$48K Sell
48,325
-51,475
-52% -$1.18M ﹤0.01% 438
2021
Q4
$100K Buy
+99,800
New +$4.01M ﹤0.01% 437

Other funds holding GDRX

Citizens Financial Group's GDRX Position: Q2 2025 in Review

Citizens Financial Group sold out of GoodRx Holdings (GDRX) in Q2 2025, closing a stake of 10,000 shares — an estimated $44.1K sold.

Citizens Financial Group first reported a position in GDRX in Q4 2021 and held it in 6 quarters. The position peaked at $100K in Q4 2021. 182 funds tracked by Wall St. Rank hold GDRX as of Q2 2025.

  • Citizens Financial Group reported no remaining GoodRx Holdings position as of Q2 2025 after selling out during the quarter.
  • Citizens Financial Group sold 10,000 GoodRx Holdings shares in Q2 2025, an estimated $44.1K.
  • Citizens Financial Group first reported a position in GoodRx Holdings in Q4 2021 and held it in 6 quarters.
  • Citizens Financial Group's GoodRx Holdings position peaked at $100K in Q4 2021.
  • 182 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2025.

Based on Citizens Financial Group's 13F filing for Q2 2025, filed 8 Aug 2025.